Capricor Therapeutics (CAPR) Stock Insights

CAPR price $6.23 +0.13 +2.13%

Ticker
CAPR
Price
$6.23
Change
+0.13 +2.13%
Market cap ?
$360.79M
P/E ?
-2.41
Forward P/E ?
30.24
Dividend yield ?
0.00%
Beta ?
0.53
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
61
Quality
42
Growth
100

Stocklytics score rationale: value 61, quality 42, growth 100.

Financials

2016201720182019202020212022202320242025
3190000266600016710001005028310250244898255146925178066222704650

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003…

Fair value

CAPR fair value $7.59. Price $6.23. Price is 18% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 3.05M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 57.91M. Net debt -269.90M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare CAPR

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.13—41.71M
2026-08-14-0.70-0.59—2.08M
2026-05-12-0.59-0.55—40.00M
2026-03-12-0.62-0.51—525.00K
2025-11-10-0.54-0.54—600.00K
2025-08-11-0.57-0.48—480.00K
2025-05-13-0.53-0.33—3.16M
2025-03-19-0.16-0.3111.13M5.50M
2024-11-13-0.38-0.362.26M9.87M
2024-08-07-0.35-0.363.97M3.58M
2024-05-13-0.31-0.114.91M9.70M
2024-02-29-0.02-0.0912.09M10.60M
2023-11-14-0.25-0.296.19M10.90M
2023-08-07-0.29-0.353.92M1.50M
2023-05-11-0.31-0.322.99M500.00K
2023-03-15-0.31-0.33959.90K10.00K
2022-11-10-0.26-0.291.59M420.00K
2022-08-10-0.29-0.25—390.00K
2022-05-10-0.32———
2022-03-10-0.26-0.19-244.65K—
2021-11-09-0.17-0.22—210.00K
2021-08-12-0.21-0.23204.08K221.83K
2021-05-13-0.23—40.82K—
2021-03-11-0.21-0.2057.83K210.00K
2020-11-12-0.20—16.86K—
2020-08-06-0.23-0.3749.86K80.21K
2020-05-14-0.30-0.33185.69K204.26K
2020-03-18-0.34-0.34222.10K222.10K
2019-11-07-0.43-0.70142.07K231.28K
2019-08-06-0.59-0.80410.35K556.41K
2019-05-13-0.80-1.10230.50K—
2019-03-28-1.10-1.60648.08K942.66K
2018-11-13-1.40-1.45219.25K227.08K
2018-08-09-1.40-1.25403.96K357.14K
2018-05-10-1.40-1.20400.07K342.86K
2018-03-14-1.10-1.00475.80K436.36K
2017-11-08-1.20-1.90313.27K490.83K
2017-08-10-1.60-1.80996.46K1.12M
2017-05-15-1.70-1.50880.81K776.47K
2017-03-15-1.40-2.40683.60K1.30M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-25Krasney KarenBuy24.10K$3.1876.64K
2026-06-25Krasney KarenSell24.10K$3.1876.64K
2026-06-25Krasney KarenSell24.10K$30.38732.16K
2026-06-25Bergmann AnthonySell24.10K$3.1876.64K
2026-06-25Bergmann AnthonyBuy24.10K$3.1876.64K
2026-06-25Bergmann AnthonySell24.10K$30.38732.16K
2026-06-24Krasney KarenSell400$3.181.27K
2026-06-24Krasney KarenBuy400$3.181.27K
2026-06-24Krasney KarenSell400$30.0012.00K
2026-06-24Bergmann AnthonySell400$3.181.27K
2026-06-24Bergmann AnthonyBuy400$3.181.27K
2026-06-24Bergmann AnthonySell400$30.0012.00K
2026-06-22Krasney KarenSell500$3.181.59K
2026-06-22Krasney KarenBuy500$3.181.59K
2026-06-22Bergmann AnthonySell500$3.181.59K
2026-06-22Bergmann AnthonyBuy500$3.181.59K
2026-05-26Maurer Michael TBuy80.00K$29.362.35M
2026-05-25Maurer Michael TOther0——
2026-05-18Bergmann AnthonyBuy3.00K$1.394.17K
2026-05-18Bergmann AnthonySell3.00K$1.394.17K
2026-05-13Litvack FrankBuy3.94K$1.395.47K
2026-05-13Litvack FrankSell3.94K$1.395.47K
2026-05-01Krasney KarenSell25.00K$3.1879.50K
2026-05-01Krasney KarenBuy25.00K$3.1879.50K
2026-05-01Krasney KarenSell25.00K$31.70792.55K
2026-05-01Bergmann AnthonySell25.00K$3.1879.50K
2026-05-01Bergmann AnthonyBuy25.00K$3.1879.50K
2026-05-01Bergmann AnthonySell25.00K$31.70792.54K
2026-04-02Sabar Karimah EsBuy7.53K$3.1823.94K
2026-04-02Sabar Karimah EsSell7.53K$3.1823.94K
2026-04-02Sabar Karimah EsSell7.53K$32.00240.93K
2026-04-01Sabar Karimah EsBuy53.73K$4.86261.15K
2026-04-01Sabar Karimah EsSell53.73K$31.031.67M
2026-04-01Sabar Karimah EsSell53.73K$4.86261.15K
2026-03-31Krasney KarenSell2.82K$3.188.96K
2026-03-31Krasney KarenSell21.49K$3.7480.37K
2026-03-31Krasney KarenBuy2.82K$3.188.96K
2026-03-31Krasney KarenBuy21.49K$3.7480.37K
2026-03-31Krasney KarenBuy693$1.39963
2026-03-31Krasney KarenSell25.00K$30.12752.93K
2026-03-31Krasney KarenSell693$1.39963
2026-03-31Sabar Karimah EsBuy61.27K$4.86297.75K
2026-03-31Sabar Karimah EsSell61.27K$4.86297.75K
2026-03-31Sabar Karimah EsSell61.27K$30.171.85M
2026-03-31Bergmann AnthonySell25.00K$3.1879.50K
2026-03-31Bergmann AnthonyBuy25.00K$3.1879.50K
2026-03-31Bergmann AnthonySell25.00K$30.13753.15K
2026-01-05Marban LindaBuy100.00K$24.812.48M
2026-01-05Marban LindaBuy50.00K$24.811.24M
2026-01-05Marban LindaBuy7.50K——
2026-01-05Bergmann AnthonyBuy25.00K$24.81620.25K
2026-01-05Bergmann AnthonyBuy2.50K——
2026-01-05Krasney KarenBuy22.50K$24.81558.23K
2026-01-05Auwaerter Paul GisbertBuy15.50K$24.81384.56K
2026-01-05Auwaerter Paul GisbertBuy5.42K$24.81134.47K
2026-01-05Auwaerter Paul GisbertBuy1.36K$24.8133.74K
2026-01-05Kelliher MikeBuy15.50K$24.81384.56K
2026-01-05Gotwals Philip JBuy15.50K$24.81384.56K
2026-01-05Sabar Karimah EsBuy15.50K$24.81384.56K
2026-01-05Musket David BBuy15.50K$24.81384.56K
2026-01-05DUNBAR GEORGE W JRBuy15.50K$24.81384.56K
2026-01-05Litvack FrankBuy50.00K$24.811.24M
2025-12-30Krasney KarenBuy2.50K$1.393.47K
2025-12-30Krasney KarenSell2.50K$1.393.47K
2025-12-19DUNBAR GEORGE W JRBuy3.00K$1.394.17K
2025-12-19DUNBAR GEORGE W JRSell3.00K$1.394.17K
2025-03-05Marban LindaSell12.50K——
2025-03-03Marban LindaBuy25.00K$1.3934.75K
2025-03-03Marban LindaSell25.00K$1.3934.75K
2025-03-03Bergmann AnthonyBuy2.50K$1.393.47K
2025-03-03Bergmann AnthonySell2.50K$1.393.47K
2025-03-03Litvack FrankBuy25.00K$1.3934.75K
2025-03-03Litvack FrankSell2.54K$13.6734.76K
2025-03-03Litvack FrankSell25.00K$1.3934.75K
2025-03-03DUNBAR GEORGE W JRBuy750$1.391.04K
2025-03-03DUNBAR GEORGE W JRSell750$1.391.04K
2025-02-27COLLIER EARL M JRBuy750$1.391.04K
2025-02-27COLLIER EARL M JRSell750$1.391.04K
2025-01-02Litvack FrankBuy50.00K$14.96748.00K
2025-01-02Bergmann AnthonyBuy75.00K$14.961.12M
2025-01-02Bergmann AnthonyBuy6.17K$14.9692.30K
2025-01-02Bergmann AnthonyBuy3.34K——
2025-01-02Krasney KarenBuy60.00K$14.96897.60K
2025-01-02Marban LindaBuy210.00K$14.963.14M
2025-01-02Marban LindaBuy34.96K$14.96523.03K
2025-01-02Kelliher MikeBuy11.94K$14.96178.62K
2025-01-02Kelliher MikeBuy5.75K$14.9686.02K
2025-01-02Kelliher MikeBuy1.44K$14.9621.54K
2025-01-02Auwaerter Paul GisbertBuy11.94K$14.96178.62K
2025-01-02Auwaerter Paul GisbertBuy5.75K$14.9686.02K
2025-01-02Auwaerter Paul GisbertBuy1.44K$14.9621.54K
2025-01-02Sabar Karimah EsBuy11.94K$14.96178.62K
2025-01-02Sabar Karimah EsBuy5.75K$14.9686.02K
2025-01-02Sabar Karimah EsBuy2.52K$14.9637.70K
2025-01-02Musket David BBuy11.94K$14.96178.62K
2025-01-02Musket David BBuy6.48K$14.9696.94K
2025-01-02Musket David BBuy5.75K$14.9686.02K
2025-01-02DUNBAR GEORGE W JRBuy11.94K$14.96178.62K
2025-01-02DUNBAR GEORGE W JRBuy5.75K$14.9686.02K
2025-01-02DUNBAR GEORGE W JRBuy3.60K$14.9653.86K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 196, holders +1 vs prior quarter. Ownership 68.17%.

HolderSharesChangeChange %Value
BLACKROCK, INC.4.15M723.25K+21.14%99.81M
TANG CAPITAL MANAGEMENT LLC4.10M700.00K+20.59%98.73M
MONTANOVA CAPITAL, LLC4.09M274.18K+7.18%98.55M
STATE STREET CORP3.40M1.22M+55.70%81.80M
VANGUARD CAPITAL MANAGEMENT LLC2.30M269.94K+13.31%55.33M
GOLDMAN SACHS GROUP INC1.58M666.15K+73.05%38.00M
RA CAPITAL MANAGEMENT, L.P.1.51M00.00%36.31M
BOXER CAPITAL MANAGEMENT, LLC1.40M805.16K+136.47%33.60M
GEODE CAPITAL MANAGEMENT, LLC1.37M253.96K+22.71%33.05M
FMR LLC1.14M365.08K+47.25%27.40M
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.06M1.01M+1894.75%25.64M
PERCEPTIVE ADVISORS LLC1.00M1.00MNew24.08M
CITADEL ADVISORS LLC814.44K477.94K+142.03%19.61M
MERCER GLOBAL ADVISORS INC /ADV802.73K399.73K+99.19%19.33M
SOLEUS CAPITAL MANAGEMENT, L.P.761.74K761.74KNew18.34M
MORGAN STANLEY684.51K260.70K+61.51%16.48M
VANGUARD PORTFOLIO MANAGEMENT LLC636.09K256.87K+67.74%15.32M
UBS GROUP AG619.66K247.68K+66.58%14.92M
DG CAPITAL MANAGEMENT, LLC611.60K219.50K+55.98%14.73M
IKARIAN CAPITAL, LLC604.22K254.22K+72.63%14.55M
DIADEMA PARTNERS LP534.40K455.55K+577.73%12.87M
SUSQUEHANNA INTERNATIONAL GROUP, LLP528.00K474.62K+889.23%12.71M
NORTHERN TRUST CORP503.53K85.99K+20.59%12.13M
PERCEPTIVE ADVISORS LLC500.00K500.00KNew12.04M
BALYASNY ASSET MANAGEMENT L.P.486.84K189.71K+63.85%11.72M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Capricor Therapeutics (CAPR) Stock Insights

CAPR$6.23+0.13 +2.13%

$360.79M

Market Cap

-2.41

P/E

30.24

Forward P/E

68

Score

Price History